Judge knocks back Purdue Pharma’s $4.5B bankruptcy settlement
Judge knocks back Purdue Pharma’s $4.5B bankruptcy settlement kdunleavy Fri, [...]
Biogen vows to contest EMA rejection of Aduhelm as EU regulators question weak link to Alzheimer’s clinical benefit
Biogen vows to contest EMA rejection of Aduhelm as EU [...]
Fierce Pharma Asia—Merck, Eisai’s failed Lenvima trial; J&J, Legend’s CAR-T data; AstraZeneca-Samsung COVID pact
Fierce Pharma Asia—Merck, Eisai’s failed Lenvima trial; J&J, Legend’s CAR-T [...]
Inozyme rebrand shows the biopharma in a fresher, purple light
Inozyme rebrand shows the biopharma in a fresher, purple light [...]
AbbVie runs ‘Migraine Relief Tok’ calming shorts, but there’s no letup for migraine marketers
AbbVie runs ‘Migraine Relief Tok’ calming shorts, but there’s no [...]
Biogen hits the gas pedal on Aduhelm confirmatory trial, hoping to deliver results in 2026
Biogen hits the gas pedal on Aduhelm confirmatory trial, hoping [...]
In its old age, Bristol Myers’ Orencia becomes first drug approved for preventing graft-versus-host disease
In its old age, Bristol Myers’ Orencia becomes first drug [...]
Eli Lilly trots out rosy 2022 projections, sees recent launches driving two-thirds of its business
Eli Lilly trots out rosy 2022 projections, sees recent launches [...]
Aerami Therapeutics, eager to breeze into smart inhaler market, unveils $250M SPAC deal
Aerami Therapeutics, eager to breeze into smart inhaler market, unveils [...]
CanSino taps Aerogen for development, commercial supply of inhaled COVID-19 vaccine hopeful
CanSino taps Aerogen for development, commercial supply of inhaled COVID-19 [...]